Blow fill seal technology aids in curbing medical non-adherence issues
Over the last three decades, poor medical adherence has posed a serious challenge for the healthcare industry as it raises a risk to patient safety as well as leads to elevated healthcare costs. To deal with the issue, the healthcare industry continually makes serious efforts to improve the use of medication through the development of unique drug delivery systems as well as packaging to ensure the right dose is taken by the patient at the right time.
In the United States specifically, it has been reported that around 50% of prescribed medications are taken incorrectly by patients and in a study conducted by IMS Health, it was reported that costs amounting to more than US$ 200 Bn are incurred in the U.S. healthcare system, due to medicines not being taken by patients responsibly. This scenario has created a demand for pharmaceutical products that have accurately measured doses and provide ease of use and level of comfort to patients. Blow fill seal technology has been extensively employed by pharmaceutical companies in North America for the manufacturing of unit dose packaging solutions as a solution to improve patient adherence to prescribed drug regimes. Moreover, packaging of medication in a single dose through blow fill seal technology ensures better drug accuracy and reduction in the contamination of drugs, due to the protective packaging.
Medication non-adherence is a substantial risk to patient wellbeing — the resulting consequences generate significant waste in healthcare, and cost even more in terms of poor patient outcomes. The expectation of better health outcome in real-world use is leading pharmaceutical companies to focus on key formulation, form and packaging tactics to deliver safer and more effective drugs to patients around the world.
Manufacturers are faced with the challenge of finding the optimum balance between cost and quality
Manufacturers have to deal with increased pressure to maintain cutting-edge standard manufacturing facilities and also to employ the most skilled workforce. But they are also faced with a challenge to reduce the cost of the final product. Moreover, government cost reduction strategies are generally focussed on generic drugs. Blow fill seal technology costs include labour, resins, straight line depreciation and maintenance, due to which pharmaceutical product manufacturers are reluctant to incorporate this technology in their manufacturing lines. Balance between cost and quality is a major challenge for the pharmaceutical packaging industry. Moreover, the pharmaceutical industry in North America is being impacted by the increasing cost of research and development and by the slow development of new drugs.
Global Blow Fill Seal (BFS) Technology Market Analysis, by Region
Being a developed region, North America has a huge medical sector that is expected to support the demand for BFS technology in the region. North America is estimated to be the market leader in terms of BFS technology and is expected to register a value CAGR of 9.8%
The APEJ region is anticipated to register a CAGR of 8.3% in terms of revenue over the forecast period and represent total incremental opportunity of US$ 763 Mn
Western Europe is expected to be the second largest region in the BFS technology market as it spends hugely on the pharmaceutical sector. The region is slated to exhibit a value CAGR of 9.1%
MEA is anticipated to be the smallest contributor in the global BFS technology market over the forecast period
Increasing demand from pharmaceutical industries is boosting the global blow fill seal technology market
The blow fill seal technology market has grown significantly over the past few years due to increasing demand from the pharmaceuticals end-use segment for unit dose packaging, and more user-friendly drug delivery systems. The shifting trend of primary packaging material from glass to plastic is further fuelling market demand for blow fill seal technology in different regions. The blow fill seal technology market is also gaining substantial footprint in the APEJ region where it aids in tackling pharmaceutical counterfeits. With a surging demand from the pharmaceutical market, growth of blow fill seal technology products such as prefilled syringes and injectable is set to increase over the forecast period. Among the material types, polypropylene and LDPE plastic material is expected to remain the prime choice of manufacturers owing to high thermo stability and high temperature sterilisation resistance property. One of the main highlights of the blow fill seal technology market is an increase in raw material options for product packaging and introduction of the new blow fill insert seal technology. North America, Western Europe, and Asia Pacific excluding Japan (APEJ) markets for blow fill seal technology are expected to witness high growth rates owing to their well-established pharmaceutical markets.
--- Analyst – Packaging, Future Market Insights
Global Blow Fill Seal Technology Market: Snapshot
The worldwide blow fill seal technology market is assessed to be esteemed at about US$ 3,122 mn in 2017. The market is relied upon to reach about US$ 7,208 mn before the finish of 2027, enrolling a CAGR of 8.7%. The worldwide sales utilization of blow fill seals is assessed to be nailed at 6,645.5 mn Units in 2017 and is relied upon to achieve 14,143.3 mn Units before the finish of 2027.
Throughout the most recent three decades, unfortunate medical adherence has represented a genuine test for the healthcare industry as it advances a hazard to tolerant wellbeing and in addition prompts lifted healthcare costs. To manage the issue, the human services industry ceaselessly attempts genuine endeavors to enhance the utilization of solution through the improvement of one of a kind systems pertaining to drug delivery and additionally packaging to guarantee the correct measurements is engaged by the patient at the opportune time.
In the United States particularly, it has been accounted for that around half of endorsed pharmaceuticals are taken mistakenly by patients and in an investigation led by IMS Health, it was accounted for that costs adding up to more than US$200 bn are acquired in the U.S. healthcare systems, because of solutions not being taken by patients capably. This situation has triggered a demand for pharmaceutical items that have precisely measured dosages and give usability and level of solace to patients.
Global Blow Fill Seal Technology Market: Key Trends
The blow fill seal technology market has become fundamentally finished the previous couple of years because of expanding request from the pharmaceuticals segment for unit measurements packaging, and easier to understand drug delivery systems. The moving pattern of essential bundling material from glass to plastic is further fuelling market interest for blow fill seal technology in various regions.
Makers need to manage expanded strain to keep up bleeding edge standard assembling offices and furthermore to utilize the most talented workforce. In any case, they are likewise looked with a test to decrease the cost of the last item. Besides, government cost decrease methodologies are for the most part focused on non-specific medications. Blow fill seal technology costs incorporate work, saps, straight line deterioration and upkeep, because of which pharmaceutical product makers are hesitant to fuse this innovation in their assembling lines.
Global Blow Fill Seal Technology Market: Regional Overview
Being a developed region, the region of North America has an immense restorative segment that is required to help the interest for BFS innovation in the locale. North America is assessed to be the market pioneer as far as BFS innovation and is relied upon to enroll an esteem CAGR of 9.8% The APEJ or Asia Pacific excluding Japan region is expected to enlist an 8.3% CAGR as far as income over the conjecture time frame and speak to add up to incremental chance of US$763 mn.
Global Blow Fill Seal Technology Market: Vendor Landscape
The companies operating in the global blow fill seal technology market are Unither Pharmaceuticals, Rommelag Kunststoff-Maschinen Vertriebsgesellschaft mbH, Catalent, Inc., Unipharma LLC, GlaxoSmithKline plc, Nephron Pharmaceuticals Corporation, and Recipharm AB, among several others.
Major regions analyzed under this research report are:
Asia Pacific excluding Japan
The Middle East and Africa
This report gives you access to decisive data such as:
Market growth drivers
Factors limiting market growth
Current market trends
Market projections for the coming years
Key highlights of this report
Overview of key market forces propelling and restraining market growth
Up-to-date analyses of market trends and technological improvements
Pin-point analyses of market competition dynamics to offer you a competitive edge
An analysis of strategies of major competitors
An array of graphics and SWOT analysis of major industry segments
Detailed analyses of industry trends
A well-defined technological growth map with an impact-analysis